Overall clinical trial disruption due to Covid-19 declines, but the number of trials with slow recruitment continues to grow

During the coronavirus (Covid-19) pandemic, companies have delayed the initiation of planned trials or withdrawn them completely. Credit: AshTproductions / Shutterstock.